Aion Therapeutic Stock Market Value

ANTCF Stock  USD 0.03  0.02  185.71%   
Aion Therapeutic's market value is the price at which a share of Aion Therapeutic trades on a public exchange. It measures the collective expectations of Aion Therapeutic investors about its performance. Aion Therapeutic is trading at 0.03 as of the 2nd of December 2024. This is a 185.71 percent increase since the beginning of the trading day. The stock's lowest day price was 0.03.
With this module, you can estimate the performance of a buy and hold strategy of Aion Therapeutic and determine expected loss or profit from investing in Aion Therapeutic over a given investment horizon. Check out Aion Therapeutic Correlation, Aion Therapeutic Volatility and Aion Therapeutic Alpha and Beta module to complement your research on Aion Therapeutic.
Symbol

Please note, there is a significant difference between Aion Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aion Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aion Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Aion Therapeutic 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aion Therapeutic's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aion Therapeutic.
0.00
12/13/2022
No Change 0.00  0.0 
In 1 year 11 months and 21 days
12/02/2024
0.00
If you would invest  0.00  in Aion Therapeutic on December 13, 2022 and sell it all today you would earn a total of 0.00 from holding Aion Therapeutic or generate 0.0% return on investment in Aion Therapeutic over 720 days. Aion Therapeutic is related to or competes with Genomma Lab. Aion Therapeutic Inc., a pharmaceutical company, offer medical cannabis products in Canada More

Aion Therapeutic Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aion Therapeutic's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aion Therapeutic upside and downside potential and time the market with a certain degree of confidence.

Aion Therapeutic Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Aion Therapeutic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aion Therapeutic's standard deviation. In reality, there are many statistical measures that can use Aion Therapeutic historical prices to predict the future Aion Therapeutic's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Aion Therapeutic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0351.53
Details
Intrinsic
Valuation
LowRealHigh
0.000.0251.52
Details
Naive
Forecast
LowNextHigh
0.00070.0362.52
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.010.010.04
Details

Aion Therapeutic Backtested Returns

Aion Therapeutic is out of control given 3 months investment horizon. Aion Therapeutic secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19% return per unit of risk over the last 3 months. We were able to break down twenty-two different technical indicators, which can help you to evaluate if expected returns of 12.11% are justified by taking the suggested risk. Use Aion Therapeutic Mean Deviation of 29.08, risk adjusted performance of 0.1568, and Standard Deviation of 62.02 to evaluate company specific risk that cannot be diversified away. Aion Therapeutic holds a performance score of 15 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -17.56, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aion Therapeutic are expected to decrease by larger amounts. On the other hand, during market turmoil, Aion Therapeutic is expected to outperform it. Use Aion Therapeutic treynor ratio and the relationship between the skewness and price action indicator , to analyze future returns on Aion Therapeutic.

Auto-correlation

    
  0.16  

Very weak predictability

Aion Therapeutic has very weak predictability. Overlapping area represents the amount of predictability between Aion Therapeutic time series from 13th of December 2022 to 8th of December 2023 and 8th of December 2023 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aion Therapeutic price movement. The serial correlation of 0.16 indicates that over 16.0% of current Aion Therapeutic price fluctuation can be explain by its past prices.
Correlation Coefficient0.16
Spearman Rank Test0.13
Residual Average0.0
Price Variance0.0

Aion Therapeutic lagged returns against current returns

Autocorrelation, which is Aion Therapeutic pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aion Therapeutic's pink sheet expected returns. We can calculate the autocorrelation of Aion Therapeutic returns to help us make a trade decision. For example, suppose you find that Aion Therapeutic has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Aion Therapeutic regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aion Therapeutic pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aion Therapeutic pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aion Therapeutic pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Aion Therapeutic Lagged Returns

When evaluating Aion Therapeutic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aion Therapeutic pink sheet have on its future price. Aion Therapeutic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aion Therapeutic autocorrelation shows the relationship between Aion Therapeutic pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Aion Therapeutic.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Aion Pink Sheet

Aion Therapeutic financial ratios help investors to determine whether Aion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Aion with respect to the benefits of owning Aion Therapeutic security.